AEPCX
Price
$58.16
Change
+$0.03 (+0.05%)
Updated
Jun 5 closing price
Net Assets
133.45B
HNCYX
Price
$20.33
Change
+$0.02 (+0.10%)
Updated
Jun 5 closing price
Net Assets
325.29M
Interact to see
Advertisement

AEPCX vs HNCYX

Header iconAEPCX vs HNCYX Comparison
Open Charts AEPCX vs HNCYXBanner chart's image
American Funds EUPAC C
Price$58.16
Change+$0.03 (+0.05%)
VolumeN/A
Net Assets133.45B
Hartford International Growth Y
Price$20.33
Change+$0.02 (+0.10%)
VolumeN/A
Net Assets325.29M
AEPCX vs HNCYX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AEPCX vs. HNCYX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and HNCYX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 133B vs. HNCYX (325M). HNCYX pays higher dividends than AEPCX: HNCYX (0.35) vs AEPCX (0.32). AEPCX was incepted earlier than HNCYX: AEPCX (24 years) vs HNCYX (24 years). AEPCX (1.59) is less costly to investors than HNCYX (0.99). HNCYX (31.00) and AEPCX (30.00) have comparable annual turnover. AEPCX has a lower initial minimum investment than HNCYX: AEPCX (250) vs HNCYX (250000). HNCYX annual gain was more profitable for investors over the last year : 12.02 vs. AEPCX (2.04). HNCYX return over 5 years is better than : 35.52 vs. AEPCX (14.22).
AEPCXHNCYXAEPCX / HNCYX
Total Expense Ratio1.590.95167%
Annual Report Gross Expense Ratio1.590.99161%
Fund Existence24 years24 years-
Gain YTD12.50214.29487%
Front LoadN/AN/A-
Min. Initial Investment2502500000%
Min. Initial Investment IRAN/AN/A-
Net Assets133B325M40,923%
Annual Yield % from dividends0.320.3594%
Returns for 1 year2.0412.0217%
Returns for 3 years14.8235.1842%
Returns for 5 years14.2235.5240%
Returns for 10 years20.6758.0136%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNN30.301.03
+3.52%
Smith & Nephew plc
APLS19.100.59
+3.19%
Apellis Pharmaceuticals
CATO2.63-0.01
-0.38%
CATO Corp
STOK10.86-0.08
-0.73%
Stoke Therapeutics
GRI1.39-0.06
-4.14%
GRI Bio Inc.